{"url_path":"/sec/pasg/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1787297/0001104659-26-058987-index.html","accession_number":"0001104659-26-058987","cik":"0001787297","ticker":"PASG","issuer_name":"Passage BIO, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1787297/0001104659-26-058987-index.html","primary_entity_key":"0001787297","primary_entity_name":"Passage BIO, Inc."},"word_count":60,"has_tables":true,"body_markdown":"Item 5. Other Information.\n\n*10b5-1 Trading Plans*\n\nDuring the three months ended March 31, 2026, none of our directors or officers, as defined in Rule 16a-1(f), informed us of the adoption, modification or termination of a “Rule 10b5-1 trading agreement” or “non-Rule 10b5-1 trading agreement,” as those terms are defined in Regulations S-K, Item 408.\n\n​\n\n41\n\n[Table of Contents](#TOC)"}